• Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

DBV Technologies SA

+ Add to Watchlist


15.7200 EUR 0.3800 2.48%

As of 11:35:00 ET on 04/17/2014.

Snapshot for DBV Technologies SA (DBV)

Open: 15.5000 Day's Range: 15.1600 - 16.0000 Volume: 15,084
Previous Close: 15.3400 52wk Range: 7.5100 - 23.5000 1-Yr Rtn: +94.07%

Stock Chart for DBV

No chart data available.
  • DBV:FP 15.7200
  • 1D
  • 1M
  • 1Y
Interactive DBV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DBV

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. CAC -
Earnings Per Share (EUR) (ttm) -1.4200
Est. EPS (EUR) (12/2014) -1.1900
Est. PEG Ratio -
Market Cap (M EUR) 237.19
Shares Outstanding (M) 15.09
30 Day Average Volume 33,666
Price/Book (mrq) -
Price/Sale (ttm) 55.7998
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DBV

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for DBV

DBV Technologies SA operates as a biopharmaceutical firm. The Company develops products and immunotherapies for the diagnosis and treatment of various food allergies. DBV Technologies delivers biological immunoactive compounds, such as allergens, to the immune system by targeting the antigen-presenting cells present in skin.

Pierre-Henri BenhamouChairman/CEO/Co-FounderDavid SchilanskyChief Financial Officer
Bertrand DupontCTO/Co-FounderVeronique FoutelChief Strategic Marketing Ofcr
More Company Profile & Key Executives for DBV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil